PAK1/2/3 Antikörper (pThr402, pThr421, pThr423)
Kurzübersicht für PAK1/2/3 Antikörper (pThr402, pThr421, pThr423) (ABIN966798)
Target
Alle PAK1/2/3 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- pThr402, pThr421, pThr423
-
Spezifität
- PAK1/PAK2/PAK3 (Phospho-Thr423/Thr402/Thr421) antibody detects endogenous levels of PAK1/PAK2/PAK3 only when phosphorylated at threonine 423/402/421.
-
Immunogen
- The antiserum was produced against synthesized phosphopeptide derived from human PAK1 around the phosphorylation site of threonine 423 (R-S-TP-M-V).
-
-
-
-
Applikationshinweise
- IHC: 1:50-1:100.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 100ug/100ul.
-
Buffer
- Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
-
: "P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary epithelium." in: The EMBO journal, Vol. 21, Issue 20, pp. 5437-47, (2002) (PubMed).
-
-
- PAK1/2/3 (P21-Activated Kinases 1/2/3 (PAK1/2/3))
-
Andere Bezeichnung
- PAK1/PAK2/PAK3
Target
-